Home » Topics » Briefs » Other news to note

Other news to note
RSS

Daiichi Sankyo advances pipeline in first quarter of fiscal 2015

Aug. 10, 2015

Immunotherapy collaboration between Juno Therapeutics and Celgene becomes effective

Aug. 7, 2015

Eisai reflects on accomplishments of first quarter of fiscal 2015

Aug. 7, 2015

Endo sells men's health businesses to Boston Scientific and plans to reorganise Litha

Aug. 6, 2015

La Jolla Pharmaceutical enters exclusive license agreements for LJPC-30Sa and LJPC-30Sb

Aug. 6, 2015

Baxalta board rejects unsolicited acquisition proposal from Shire

Aug. 6, 2015

GSK reviews progress of late-stage pipeline in second quarter 2015

Aug. 6, 2015

Sorrento Therapeutics licenses ex-Chinese rights to Mabtech Ltd biologics

Aug. 6, 2015

Astellas review progress of first quarter of fiscal 2015

Aug. 6, 2015

Mitsubishi Tanabe Pharma presents milestones of first quarter of fiscal 2015

Aug. 5, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...